Company: SCLXW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283153
Chunk: 4

Company: Scilex Holding Co
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 4
---
 issuance costs

     —

     845

     Purchased revenue liability, net of current portion

     11,442

     2,685

     Derivative liabilities

     81,982

     18,303

     Operating lease liabilities, net of current portion

     918

     1,523

     Other long-term liabilities

     169

     155

     Total liabilities

     455,598

     285,594

     Commitments and contingencies (See Note 12)

     Stockholders’ deficit:

     Preferred stock, $0.0001 par value, 45,000,000 shares authorized

     Series A, 29,057,097 shares issued and outstanding as of each of September 30, 2025 and December 31, 2024

     —

     —

     Series 1, 5,000,000 shares declared as a stock dividend, not yet distributed as of each of September 30, 2025 and December 31, 2024

     1

     1

     Common stock, $0.0001 par value, 740,000,000 shares authorized; 7,585,446 shares issued and 5,947,947 shares outstanding as of September 30, 2025; 6,951,622 shares issued and 5,235,377 shares outstanding as of December 31, 2024

     1

     1

     Additional paid-in capital

     785,304

     454,614

     Accumulated other comprehensive income

     3,347

     6,317

     Accumulated deficit

     (888,674
     )

     (563,052
     )

     Treasury stock, at cost; 1,458,263 and 1,716,245 shares as of September 30, 2025 and December 31, 2024, respectively

     (76,915
     )

     (90,522
     )

     Total stockholders’ deficit

     (176,936
     )

     (192,641
     )

     Noncontrolling interests

     (2,783
     )

     —

     Total Scilex Holding Company stockholders’ deficit

     (179,719
     )

     (192,641
     )

     Total liabilities and stockholders’ deficit